Dentsply Sirona Expands Symbios Allograft Offering for Dental Surgery

Dentsply Sirona, a leader in dental technology, has expanded its Symbios Allograft product line to better support dental surgery and implant procedures. By introducing enhanced versions of its mineralized and demineralized allografts, the company aims to improve bone regeneration, formation, and stability—ultimately leading to more predictable, long-term outcomes for patients and clinicians alike.

As the world’s largest manufacturer of professional dental products, Dentsply strives to provide  solutions for oral health practices worldwide. Their refreshed Symbios Allograft line is tailored to meet the diverse needs of dental professionals engaged in complex surgical procedures. The new offerings, including different granule sizes and putty products, reflect the company’s commitment to precision, sterility, and scientific rigor.

 Collaborating with trusted partners like RegenX and MTF Biologics, Dentsply Sirona ensures that its products adhere to the highest standards of donor screening and inspection, safeguarding both clinicians and patients. This development is crucial as it signifies an ongoing advancement in the regenerative dental market, which remains a vital part of modern dentistry.

Dentsply Sirona’s enhanced Symbios Allograft range shows its dedication to advancing dental care through innovation and superior product development. By providing solutions that offer reliability and excellence, the company continues to solidify its position as a leader in the dental industry. Through this expansion, dental professionals are empowered to achieve better surgical outcomes, paving the way for improved patient care.

For the latest updates and in-depth insights into the world of Dentistry, including breakthrough treatments, industry trends, and regulatory news, contact Brooke Latham today!